NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial (NCT04750616)

🧪 Interventions in This Study

• Niacinamide (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Kaiser Permanente San Francisco Medical Center — San Francisco, California

📞 Contact the Study Coordinator

Phone: (415) 264-4750

Email: ali.x.poyanmehr@kp.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Ischemia Reperfusion Injury

• Intravenous Estrogen in Kidney Transplant Study — Philadelphia, Pennsylvania
• Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation — Providence, Rhode Island

Explore by condition: All Ischemia Reperfusion Injury clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.